Carla Sans‐Pola

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management

Marta Miarons, María Larrosa-García, Sonia García-García et al. · Transplantation · 2020 · 63 citations

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta et al. · The Lancet Regional Health - Europe · 2023 · 31 citations · Full text

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Carla Sans‐Pola, Imma Danés, Josep Ángel Bosch et al. · Frontiers in Medicine · 2023 · 18 citations · Full text

Clinical Pharmacology

Émilie Jouanjus, Carla Sans‐Pola, Pau Alcubilla et al. · British Journal of Pharmacology · 2023 · 11 citations · Full text